Cortexyme, Inc. Separation Agreements
6 Contracts & Agreements
- Transition and Separation Agreement between Quince Therapeutics, Inc. and Karen Smith, dated as of August 4, 2023 (Filed With SEC on November 14, 2023)
- Separation Agreement, by and between Cortexyme, Inc. and Leslie Holsinger, dated as of July 31, 2022 (Filed With SEC on August 9, 2022)
- Separation Agreement, by and between Cortexyme, Inc. and Christopher Lowe, dated as of June 10, 2022 (Filed With SEC on August 9, 2022)
- Separation Agreement, by and between Cortexyme, Inc. and Caryn G. McDowell, dated as of May 19, 2022 (Filed With SEC on August 9, 2022)
- Separation Agreement, by and between Cortexyme, Inc. and Michael Detke, dated as of May 2, 2022 (Filed With SEC on August 9, 2022)
- Separation Agreement by and between Kristen Gafric and Cortexyme, Inc., dated as of April 27, 2020 (Filed With SEC on August 14, 2020)
